Physician profile
Sandra Mini
NPI 1255344198
$2,027.43
in general payments reported to CMS, 2019-2025
18 companies · $740 in 2025
The $740 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.29 · 2023: $727 · 2024: $543 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,010.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $310.21 | 2023-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $300.27 | 2023-2024 | |
| Novo Nordisk INC | $223.84 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $200.75 | 2023-2025 | Breztri, Farxiga |
| Medtronic, INC. | $156.39 | 2025 | Endurant Iis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.35 | 2023-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $113.55 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $106.82 | 2023-2025 | Jardiance, Emgality, Mounjaro |
| Pfizer INC. | $99.77 | 2023-2025 | |
| Exact Sciences Corporation | $84.47 | 2023-2025 | Cologuard Collection Kit |
| Intra-Sana Laboratories | $68.95 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Merck Sharp & Dohme LLC | $61.18 | 2023-2025 | Gardasil 9, Capvaxive, Gardasil |
| Biomerieux INC | $38.71 | 2025 | Biofire Spotfire Control Station |
| Bayer Healthcare Pharmaceuticals INC. | $27.89 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.66 | 2023 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $23.17 | 2024 | Veozah |
| Tempus Ai, INC | $22.38 | 2024 | Xt Cdx |
| Bausch Health US, LLC | $20.07 | 2025 | Wellbutrin, Aplenzin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Mini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.